Research Points to Translational Path Toward Precision Immunotherapies for EGFR-Mutant NSCLC

Regulating Artificial Intelligence

Wu-Kong28 Data Support Sunvozertinib as First-Line Treatment Option for EGFR-Mutant NSCLC, Researcher Says

… as First-Line Treatment Option for EGFR-Mutant NSCLC, Researcher Says … Haleigh Behrman …

Funding Opportunities for Innovative Multidisciplinary Cancer Research Teams

… Opportunities for Innovative Multidisciplinary Cancer Research Teams …

Narrow Focus Allows Pragmatica-Lung Trial to Minimize Eligibility Criteria, Significantly Reduce Data Collection, Researcher Says

… Criteria, Significantly Reduce Data Collection, Researcher Says … Erin Jungmeyer …

Pragmatic Approach to Trial Design Born from Lung-MAP Substudy

… new pragmatic approach to trial design can streamline research and ultimately benefit patients. … Pragmatic Approach …

Real-World Data from Taiwan Shows Stage Shift Has Improved Lung Cancer Survival Rates

… Researchers say increased screening of at-risk populations, …

Keynote Address Explores the Future of Biomarkers in the ADC Era

… R. Hirsch outlined the current state of knowledge in ADC research, as well as what still needs to be learned. … Keynote …

US FDA’s Review of Single-Country ‘Me Too’ Drugs: A Clinical Trialist Perspective

… of care and limited resources to review applications, researchers say they support the agency’s decision not to …

US FDA Grants Breakthrough Therapy Designation for Novel TKI Targeting HER2, EGFR

… In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited …